MiR-182 targets CHL1 and controls tumor growth and invasion in papillary thyroid carcinoma

Biochemical and Biophysical Research Communications

Volumn 450, Issue 1, 2014, Pages 857-862

  Zhu, Hongling ^a   Fang, Jin ^b   Zhang, Jichen ^a   Zhao, Zefei ^a   Liu, Lianyong ^a   Wang, Jingnan ^a   Xi, Qian ^a   Gu, Mingjun ^a  

^a Shanghai Pudong New Area Gongli Hospital   (China)

^b The 118th PLA Hospital   (China)

Author keywords

CHL1; Invasion; miR 182; Papillary thyroid carcinoma; Proliferation

Indexed keywords

CHL1 PROTEIN; MESSENGER RNA; MICRORNA 182; PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; THYROID CANCER CELL LINE; THYROID CARCINOMA; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING;

CHL1; INVASION; MIR-182; PAPILLARY THYROID CARCINOMA; PROLIFERATION;

ANIMALS; CARCINOMA; CELL PROLIFERATION; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84904748494     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.06.073     Document Type: Article

References (30)

1. A. Jemal, L.X. Clegg, E. Ward, L.A. Ries, X. Wu, P.M. Jamison, P.A. Wingo, H.L. Howe, R.N. Anderson, and B.K. Edwards Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival Cancer 101 2004 3 27
2. H. He, K. Jazdzewski, W. Li, S. Liyanarachchi, R. Nagy, S. Volinia, G.A. Calin, C.G. Liu, K. Franssila, S. Suster, R.T. Kloos, C.M. Croce, and A. de la Chapelle The role of microRNA genes in papillary thyroid carcinoma Proc. Natl. Acad. Sci. U.S.A. 102 2005 19075 19080
3. C.K. Chou, K.D. Yang, F.F. Chou, C.C. Huang, Y.W. Lan, Y.F. Lee, H.Y. Kang, and R.T. Liu Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma J. Clin. Endocrinol. Metab. 98 2013 E196 E205
4. B.H. Lang, K.P. Wong, K.Y. Wan, and C.Y. Lo Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection Ann. Surg. Oncol. 19 2012 1257 1263
5. G.A. Calin, and C.M. Croce MicroRNA-cancer connection: the beginning of a new tale Cancer Res. 66 2006 7390 7394
6. Yu T, Liu K, Wu Y, Fan J, Chen J, Li C, Yang Q, Wang Z, MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway, Oncogene (2013). doi: 10.1038/onc.2013.448. [Epub ahead of print].
7. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat. Rev. Cancer 6 2006 857 866
8. C.K. Chou, R.F. Chen, F.F. Chou, H.W. Chang, Y.J. Chen, Y.F. Lee, K.D. Yang, J.T. Cheng, C.C. Huang, and R.T. Liu miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation Thyroid 20 2010 489 494
9. X. Zhang, M. Li, K. Zuo, D. Li, M. Ye, L. Ding, H. Cai, D. Fu, Y. Fan, and Z. Lv Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling J. Clin. Endocrinol. Metab. 98 2013 E1305 E1313
10. Y. Ma, H. Qin, and Y. Cui MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway Biochem. Biophys. Res. Commun. 441 2013 958 963
11. Minna E, Romeo P, De Cecco L, Dugo M, Cassinelli G, Pilotti S, Degl'innocenti D, Lanzi C, Casalini P, Pierotti MA, Greco A, Borrello MG, miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma, Oncotarget (2014). [Epub ahead of print].
12. C.H. Chiang, M.F. Hou, and W.C. Hung Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK Biochim. Biophys. Acta 1830 2013 3067 3076
13. M. Swierniak, A. Wojcicka, M. Czetwertynska, E. Stachlewska, M. Maciag, W. Wiechno, B. Gornicka, M. Bogdanska, L. Koperski, A. de la Chapelle, and K. Jazdzewski In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma J. Clin. Endocrinol. Metab. 98 2013 E1401 E1409
14. R.S. Schmid, and P.F. Maness L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth Curr. Opin. Neurobiol. 18 2008 245 250
15. M.J. Long, F.X. Wu, P. Li, M. Liu, X. Li, and H. Tang MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells Cancer Lett. 324 2012 186 196
16. Y. Chu, Y. Ouyang, F. Wang, A. Zheng, L. Bai, L. Han, Y. Chen, and H. Wang MicroRNA-590 promotes cervical cancer cell growth and invasion by targeting CHL1 J. Cell. Biochem. 115 2014 847 853
17. L.H. He, Q. Ma, Y.H. Shi, J. Ge, H.M. Zhao, S.F. Li, and Z.S. Tong CHL1 is involved in human breast tumorigenesis and progression Biochem. Biophys. Res. Commun. 438 2013 433 438
18. K. Uchida, A. Oga, M. Nakao, T. Mano, M. Mihara, S. Kawauchi, T. Furuya, Y. Ueyama, and K. Sasaki Loss of 3p26.3 is an independent prognostic factor in patients with oral squamous cell carcinoma Oncol. Rep. 26 2011 463 469
19. Wang G, Cao X, Lai S, Luo X, Feng Y, Wu J, Ning Q, Xia X, Wang J, Gong J, Hu J, Altered p53 regulation of miR-148b and p55PIK contributes to tumor progression in colorectal cancer, Oncogene (2014). doi: 10.1038/onc.2014.30. [Epub ahead of print]
20. M. Wang, H. Gu, H. Qian, W. Zhu, C. Zhao, X. Zhang, Y. Tao, L. Zhang, and W. Xu miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation Eur. J. Cancer 49 2013 2010 2021
21. K.A. O'Donnell, E.A. Wentzel, K.I. Zeller, C.V. Dang, and J.T. Mendell c-Myc-regulated microRNAs modulate E2F1 expression Nature 435 2005 839 843
22. Zhou X, Zhang CZ, Lu SX, Chen GG, Li LZ, Liu LL, Yi C, Fu J, Hu W, Wen JM, Yun JP, miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma, Oncogene (2014). doi: 10.1038/onc.2014.35. [Epub ahead of print].
23. L. Jiang, P. Mao, L. Song, J. Wu, J. Huang, C. Lin, J. Yuan, L. Qu, S.Y. Cheng, and J. Li miR-182 as a prognostic marker for glioma progression and patient survival Am. J. Pathol. 177 2010 29 38
24. W. Zhu, X. Liu, J. He, D. Chen, Y. Hunag, and Y.K. Zhang Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study BMC Cancer 11 2011 393
25. Liu Z, Liu J, Segura MF, Shao C, Lee P, Gong Y, Hernando E, Wei JJ, MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma, J. Pathol. 228 (2012) 204-215.
26. Lei R, Tang J, Zhuang X, Deng R, Li G1, Yu J, Liang Y, Xiao J, Wang HY, Yang Q, Hu G, Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis. Oncogene 33 (2014) 1287-1296.
27. S.S. Myatt, J. Wang, L.J. Monteiro, M. Christian, K.K. Ho, L. Fusi, R.E. Dina, J.J. Brosens, S. Ghaem-Maghami, and E.W. Lam Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer Cancer Res. 70 2010 367 377
28. W.Q. Kong, R. Bai, T. Liu, C.L. Cai, M. Liu, X. Li, and H. Tang MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma FEBS J. 279 2012 1252 1260
29. M.H. Wei, I. Karavanova, S.V. Ivanov, N.C. Popescu, C.L. Keck, S. Pack, J.A. Eisen, and M.I. Lerman In silico-initiated cloning and molecular characterization of a novel human member of the L1 gene family of neural cell adhesion molecules Hum. Genet. 103 1998 355 364
30. V.N. Senchenko, G.S. Krasnov, A.A. Dmitriev, A.V. Kudryavtseva, E.A. Anedchenko, E.A. Braga, I.V. Pronina, T.T. Kondratieva, S.V. Ivanov, E.R. Zabarovsky, and M.I. Lerman Differential expression of CHL1 gene during development of major human cancers PLoS One 6 2011 e15612